Mark Haas, MD, PhD
Professor of Pathology
Education and Training
- Duke University, Durham, NC; MD
- Duke University, Durham, NC; PhD
- Residency in Anatomic Pathology, Yale - New Haven Medical Center, New Haven, CT
- Fellowship in Renal Pathology, Yale - New Haven Medical Center, New Haven, CT
Medical Board Certification
- Board Certified, Anatomic Pathology
Clinical and Research Interests
- Renal Pathology, including glomerular diseases and transplantation pathology
Awards and Activities
- Past-President, Renal Pathology Society
- Recipient, Jacob Churg Award, Renal Pathology Society
- Editorial Board Member, Kidney International
- Section Editor (Glomerular Diseases), Clinical Nephrology
- Soloviova K., Puliaiev M, Haas M, Via CS. In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-vs-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor. J. Immunol. 2013 (In press).
- Haas M. Pathology of C4d-negative antibody-mediated rejection in renal allografts. Curr Opin Organ Transplant. 2013 (In press).
- Haas M, Reich HN. Morphologic markers of progressive immunoglobulin A nephropathy. Adv Chronic Kidney Dis. 2012; 19:107-13.
- Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum. Curr Opin Nephrol Hypertens. 2012; 21:264-71.
- Mengel M, Sis B, Haas M, Colvin RB, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant. 2012;12:563-70.
Click here for a list of peer-reviewed publications by Mark Haas, MD, PhD.